Kodiak Sciences Cash Flow Statement
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
99.87+5.61 (+5.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kodiak Sciences free cash flow
In fiscal 2025, Kodiak Sciences generated -$136.0 million of operating cash flow and spent $506,000 on capital expenditures. That left free cash flow of -$136.5 million.
Summary generated from market data by MetaCap's automated system. Methodology
Kodiak Sciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -229.97M | -176.21M | -260.49M | -333.82M | -266.99M | -133.10M | -47.37M | -41.44M | -27.94M | -17.13M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 18.33M | 18.71M | 18.30M | 3.80M | 1.00M | 477.00K | 538.00K | 490.00K | 549.00K | 257.00K |
| Stock-Based Compensation | 58.86M | 60.21M | 88.56M | 106.03M | 61.38M | 30.67M | 6.11M | 2.67M | 275.00K | 272.00K |
| Change in Working Capital | 8.13M | -9.71M | 6.02M | 9.04M | -629.00K | 3.41M | -2.94M | -2.29M | 2.34M | 44.00K |
| Operating Cash Flow | -136.01M | -117.32M | -154.18M | -206.46M | -182.27M | -83.43M | -39.15M | -29.03M | -17.66M | -16.05M |
| Capital Expenditures | -506.00K | -375.00K | -41.35M | -37.02M | -17.03M | -3.81M | -437.00K | -78.00K | -209.00K | -771.00K |
| Investing Cash Flow | -506.00K | -755.00K | 249.23M | -336.51M | -38.80M | 104.83M | -137.00M | -581.00K | -209.00K | -771.00K |
| Share Repurchases | — | — | — | — | — | — | — | 0 | 0 | -4.00K |
| Financing Cash Flow | 178.30M | 501.00K | 31.00K | 1.90M | 8.18M | 717.38M | 299.69M | 116.47M | 9.64M | -120.00K |
| Net Change in Cash | 41.79M | -117.57M | 95.07M | -541.08M | -212.89M | 738.78M | 123.54M | 86.86M | -8.23M | -16.94M |
| Free Cash Flow | -136.51M | -117.69M | -195.53M | -243.48M | -199.30M | -87.24M | -39.58M | -29.11M | -17.86M | -16.82M |
This table shows 10 annual periods of Kodiak Sciences's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KOD's reporting calendar. What is a cash flow statement?